Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Jun 22, 2018 (8 years ago)

eb5 Skincare that Works. Age Spot Treatment. Skin Lightening…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed Stability Specifications: Out-of-specification for viscosity, pH and specific gravity

Cause type: Stability / shelf life

The product degraded or failed stability testing before its labeled expiry. Heat, moisture or time can break the drug down into degradants or reduce potency. All stability / shelf life recalls.

What was recalled

eb5 Skincare that Works. Age Spot Treatment. Skin Lightening Cream with 2% Hydroquinone. 177.4 ml / 6 fl oz carton containing a tube. Manufactured For: EB5 Corporation Portland, OR 97210 Carton Bar Code: 7 41099 00009 9

Drug: Hydroquinone

Recalling firm
Eb5 Corporation
Origin
OR, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0908-2018 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Hydroquinone recalls

See all
Class II · Moderate risk

Hydroquinone USP

Finished product specification did not meet USP specifications.

Terminated Other Monarch PCM, LLC NDC 69367-174-01 D-0855-2021
Class III · Low risk

Hydroquinone

Subpotency: one product for active ingredient assay and another one for preservative assay

Terminated Wrong potency / content Monarch PCM, LLC NDC 69367-174-01 D-0818-2021
Class II · Moderate risk

Dermanak original crema blanqueador

CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.

Terminated Stability / shelf life Pharma-Natural Inc. NDC 63788-108-02 D-1500-2019

Other stability / shelf life recalls from 2018

All stability / shelf life recalls
Class III · Low risk

Megestrol Acetate Oral Suspension

Failed Stability Specifications: Out-of-Specification results obtained for particle size distribution during stability testing.

Terminated Stability / shelf life Breckenridge Pharmaceutical, Inc. D-0279-2019
Class II · Moderate risk

Nystatin and Triamcinolone Acetonide Cream

Failed stability specifications - An out of specification result was observed for the test parameter : composition of Nystatin during stability testing.

Terminated Stability / shelf life Dr. Reddy's Laboratories, Inc. NDC 43598-431-44 D-0007-2019